Epidemiology provides principles and methods that can be used to investigate almost any aspect of health or disease in human populations, from discovering a new cause of cancer to evaluating the effectiveness of a public health program. Epidemiologic research is inherently multidisciplinary and collaborative, often involving experts from diverse fields such as medicine, biostatistics, exposure assessment, genetics or social science, as well as epidemiologists.
Faculty and students in the Department of Epidemiology engage in a wide range of research projects in Nebraska and around the world.
AEG - Applied Epidemiology Group - The AEG focuses on practice-based public health, including building, maintaining, and evaluating surveillance systems and data, conducting field, environmental, and outbreak investigations, and implementing public health programs and interventions.
DECODE Lab - Disparities Epidemiology in ChrOnic Diseases and the Environment - The DECODE lab uses classic and molecular epidemiologic tools to examine environmental and biologic heterogeneity and susceptibility of cancer and other chronic diseases.
EMH Group - Epidemiology of Malaria and Helminthiasis - The research group EMH is focused on understanding the epidemiological, immunological and clinical basis of interaction between malaria and helminth infection and using the information to control these diseases in endemic regions.
ETEG - Emerging Threats Epidemiology Group - The ETEG focuses on epidemiologic aspects of health security risk, oriented towards impact on patient and community centered outcomes.
HAUSS Lab - Healthcare Access, Utilization, Sociodemographic & Spatial Factors - The HAUSS lab focuses on cancer health disparities through the lens of the social determinants of health (SDOH) using a socio-ecological perspective, with particular foci on healthcare access and utilization and the intersection of race/ethnicity, rurality, and other identities.
PCER Lab - Pediatric Cancer Epidemiology Research - The PCER Lab focuses on cancer care issues (e.g., symptom clusters and financial toxicity) and the roles of physical and social environment play in development and outcomes of pediatric cancer.